Cooper Gross Margin 2012-2026 | COO
Current and historical gross margin for Cooper (COO) over the last 10 years. The current gross profit margin for Cooper as of July 31, 2026 is %.
| Cooper Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-07-31 | $4.24B | $2.79B | 65.92% |
| 2026-04-30 | $4.23B | $2.77B | 65.54% |
| 2026-01-31 | $4.15B | $2.72B | 65.45% |
| 2025-10-31 | $4.09B | $2.68B | 65.54% |
| 2025-07-31 | $4.05B | $2.71B | 66.97% |
| 2025-04-30 | $3.99B | $2.68B | 67.20% |
| 2025-01-31 | $3.93B | $2.63B | 66.99% |
| 2024-10-31 | $3.90B | $2.60B | 66.63% |
| 2024-07-31 | $3.81B | $2.52B | 66.33% |
| 2024-04-30 | $3.73B | $2.47B | 66.21% |
| 2024-01-31 | $3.67B | $2.42B | 66.09% |
| 2023-10-31 | $3.59B | $2.36B | 65.63% |
| 2023-07-31 | $3.51B | $2.29B | 65.14% |
| 2023-04-30 | $3.43B | $2.23B | 65.10% |
| 2023-01-31 | $3.38B | $2.18B | 64.53% |
| 2022-10-31 | $3.31B | $2.14B | 64.69% |
| 2022-07-31 | $3.22B | $2.11B | 65.39% |
| 2022-04-30 | $3.14B | $2.07B | 65.91% |
| 2022-01-31 | $3.03B | $2.02B | 66.79% |
| 2021-10-31 | $2.92B | $1.96B | 66.92% |
| 2021-07-31 | $2.85B | $1.88B | 65.99% |
| 2021-04-30 | $2.66B | $1.72B | 64.75% |
| 2021-01-31 | $2.47B | $1.56B | 63.26% |
| 2020-10-31 | $2.43B | $1.54B | 63.18% |
| 2020-07-31 | $2.44B | $1.57B | 64.20% |
| 2020-04-30 | $2.54B | $1.66B | 65.18% |
| 2020-01-31 | $2.67B | $1.77B | 66.12% |
| 2019-10-31 | $2.65B | $1.76B | 66.26% |
| 2019-07-31 | $2.61B | $1.73B | 66.32% |
| 2019-04-30 | $2.59B | $1.71B | 65.88% |
| 2019-01-31 | $2.57B | $1.68B | 65.38% |
| 2018-10-31 | $2.53B | $1.63B | 64.47% |
| 2018-07-31 | $2.44B | $1.56B | 63.69% |
| 2018-04-30 | $2.34B | $1.49B | 63.49% |
| 2018-01-31 | $2.23B | $1.42B | 63.86% |
| 2017-10-31 | $2.14B | $1.37B | 63.81% |
| 2017-07-31 | $2.10B | $1.31B | 62.40% |
| 2017-04-30 | $2.06B | $1.27B | 61.75% |
| 2017-01-31 | $2.02B | $1.22B | 60.68% |
| 2016-10-31 | $1.97B | $1.17B | 59.65% |
| 2016-07-31 | $1.91B | $1.13B | 59.37% |
| 2016-04-30 | $1.85B | $1.09B | 58.69% |
| 2016-01-31 | $1.80B | $1.06B | 58.57% |
| 2015-10-31 | $1.80B | $1.07B | 59.51% |
| 2015-07-31 | $1.81B | $1.10B | 60.61% |
| 2015-04-30 | $1.78B | $1.11B | 62.08% |
| 2015-01-31 | $1.76B | $1.11B | 62.89% |
| 2014-10-31 | $1.72B | $1.09B | 63.60% |
| 2014-07-31 | $1.66B | $1.08B | 64.78% |
| 2014-04-30 | $1.64B | $1.06B | 64.78% |
| 2014-01-31 | $1.61B | $1.05B | 65.03% |
| 2013-10-31 | $1.59B | $1.03B | 64.61% |
| 2013-07-31 | $1.57B | $1.02B | 64.57% |
| 2013-04-30 | $1.54B | $0.99B | 64.17% |
| 2013-01-31 | $1.50B | $0.95B | 63.64% |
| 2012-10-31 | $1.45B | $0.92B | 63.94% |
| 2012-07-31 | $1.41B | $0.90B | 63.48% |
| 2012-04-30 | $1.38B | $0.86B | 62.04% |
| 2012-01-31 | $1.36B | $0.84B | 61.56% |
| 2011-10-31 | $1.33B | $0.81B | 60.60% |
| 2011-07-31 | $1.28B | $0.77B | 59.98% |
| 2011-04-30 | $1.23B | $0.74B | 60.47% |
| 2011-01-31 | $1.19B | $0.70B | 59.03% |
| 2010-10-31 | $1.16B | $0.68B | 58.38% |
| 2010-07-31 | $1.13B | $0.65B | 57.45% |
| 2010-04-30 | $1.12B | $0.62B | 55.33% |
| 2010-01-31 | $1.09B | $0.60B | 55.46% |
| 2009-10-31 | $1.08B | $0.60B | 55.19% |
| 2009-07-31 | $1.06B | $0.60B | 56.30% |
| 2009-04-30 | $1.06B | $0.61B | 57.47% |
| 2009-01-31 | $1.06B | $0.61B | 57.67% |
| 2008-10-31 | $1.05B | $0.61B | 58.21% |
| 2008-07-31 | $1.03B | $0.57B | 54.91% |
| 2008-04-30 | $1.00B | $0.56B | 55.49% |
| 2008-01-31 | $0.97B | $0.53B | 54.90% |
| 2007-10-31 | $0.95B | $0.52B | 54.92% |
| 2007-07-31 | $0.91B | $0.53B | 58.05% |
| 2007-04-30 | $0.89B | $0.52B | 58.85% |
| 2007-01-31 | $0.87B | $0.53B | 60.44% |
| 2006-10-31 | $0.86B | $0.53B | 61.23% |
| 2006-07-31 | $0.86B | $0.53B | 61.69% |
| 2006-04-30 | $0.86B | $0.53B | 62.02% |
| 2006-01-31 | $0.87B | $0.53B | 61.73% |
| 2005-10-31 | $0.81B | $0.50B | 61.59% |
| 2005-07-31 | $0.72B | $0.45B | 62.20% |
| 2005-04-30 | $0.62B | $0.39B | 62.60% |
| 2005-01-31 | $0.53B | $0.34B | 63.71% |
| 2004-10-31 | $0.49B | $0.32B | 64.15% |
| 2004-07-31 | $0.47B | $0.31B | 64.69% |
| 2004-04-30 | $0.45B | $0.29B | 64.60% |
| 2004-01-31 | $0.43B | $0.28B | 64.64% |
| 2003-10-31 | $0.41B | $0.27B | 64.48% |
| 2003-07-31 | $0.39B | $0.25B | 64.12% |
| 2003-04-30 | $0.38B | $0.24B | 63.56% |
| 2003-01-31 | $0.35B | $0.22B | 62.78% |
| 2002-10-31 | $0.32B | $0.20B | 62.97% |
| 2002-07-31 | $0.29B | $0.18B | 63.07% |
| 2002-04-30 | $0.26B | $0.16B | 63.81% |
| 2002-01-31 | $0.24B | $0.16B | 64.88% |
| 2001-10-31 | $0.23B | $0.15B | 65.38% |
| 2001-07-31 | $0.22B | $0.15B | 65.47% |
| 2001-04-30 | $0.21B | $0.14B | 66.20% |
| 2001-01-31 | $0.21B | $0.14B | 65.70% |
| 2000-10-31 | $0.20B | $0.13B | 65.99% |
| 2000-07-31 | $0.19B | $0.12B | 65.78% |
| 2000-04-30 | $0.18B | $0.12B | 65.36% |
| 2000-01-31 | $0.17B | $0.11B | 65.88% |
| 1999-10-31 | $0.17B | $0.11B | 64.85% |
| 1999-07-31 | $0.16B | $0.14B | 86.34% |
| 1999-04-30 | $0.16B | $0.12B | 77.85% |
| 1999-01-31 | $0.15B | $0.11B | 69.93% |
| 1998-10-31 | $0.15B | $0.09B | 61.22% |
| 1998-07-31 | $0.13B | $0.03B | 25.76% |
| 1998-04-30 | $0.12B | $0.03B | 23.08% |
| 1998-01-31 | $0.10B | $0.02B | 18.81% |
| 1997-10-31 | $0.09B | $0.02B | 16.85% |
| 1997-07-31 | $0.09B | $0.02B | 21.28% |
| 1997-04-30 | $0.10B | $0.03B | 28.57% |
| 1997-01-31 | $0.10B | $0.04B | 35.58% |
| 1996-10-31 | $0.11B | $0.05B | 44.95% |
| 1996-07-31 | $0.10B | $0.05B | 46.60% |
| 1996-04-30 | $0.10B | $0.05B | 46.46% |
| 1996-01-31 | $0.10B | $0.04B | 44.79% |
| 1995-10-31 | $0.10B | $0.04B | 40.21% |
| 1995-07-31 | $0.10B | $0.04B | 39.58% |
| 1995-04-30 | $0.10B | $0.04B | 37.89% |
| 1995-01-31 | $0.10B | $0.04B | 37.89% |
| 1994-10-31 | $0.10B | $0.04B | 37.89% |
| 1994-07-31 | $0.09B | $0.03B | 36.56% |
| 1994-04-30 | $0.09B | $0.03B | 36.56% |
| 1994-01-31 | $0.09B | $0.03B | 36.56% |
| 1993-10-31 | $0.09B | $0.03B | 35.87% |
| 1993-07-31 | $0.09B | $0.03B | 28.26% |
| 1993-04-30 | $0.09B | $0.03B | 36.78% |
| 1993-01-31 | $0.07B | $0.03B | 39.19% |
| 1992-10-31 | $0.06B | $0.03B | 42.86% |
| 1992-07-31 | $0.05B | $0.03B | 60.78% |
| 1992-04-30 | $0.04B | $0.02B | 51.22% |
| 1992-01-31 | $0.04B | $0.02B | 51.28% |
| 1991-10-31 | $0.04B | $0.02B | 51.43% |
| 1991-07-31 | $0.04B | $0.02B | 57.89% |
| 1991-04-30 | $0.04B | $0.02B | 60.00% |
| 1991-01-31 | $0.04B | $0.03B | 61.36% |
| 1990-10-31 | $0.05B | $0.03B | 61.70% |
| 1990-07-31 | $0.05B | $0.03B | 58.70% |
| 1990-04-30 | $0.05B | $0.03B | 58.70% |
| 1990-01-31 | $0.05B | $0.03B | 60.42% |
| 1989-10-31 | $0.05B | $0.03B | 60.38% |
| 1989-07-31 | $-0.51B | $-0.22B | 43.39% |
| 1989-04-30 | $-0.30B | $-0.13B | 41.39% |
| 1989-01-31 | $-0.09B | $-0.03B | 29.41% |
| 1988-10-31 | $0.13B | $0.08B | 59.06% |
| 1988-04-30 | $0.63B | $0.31B | 49.60% |
| 1988-01-31 | $0.49B | $0.25B | 50.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $10.130B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |